“Medical cannabis therapy was associated with reductions in opioid use (− 89.8 percent), pain intensity (− 84.2 percent), and functional disability (− 30.4 percent).”
The post 10-Year Study: Back Pain Patients Report Sustained Improvements, Decreased Reliance on Pharmaceuticals Following Medical Cannabis Treatment appeared first on NORML.
“Medical cannabis therapy was associated with reductions in opioid use (− 89.8 percent), pain intensity (− 84.2 percent), and functional disability (− 30.4 percent).”
The post 10-Year Study: Back Pain Patients Report Sustained Improvements, Decreased Reliance on Pharmaceuticals Following Medical Cannabis Treatment appeared first on NORML.Research, back pain, benzodiazepines, chronic pain, gabapentin, Israel, medical cannabis, opioids, pharmaceuticals
